Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26482279

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2015 Nov
First author
Motzer RJ

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Nov;16(15):1441-1442. doi: 10.1016/S1470-2045(15)00325-3.
    note
    Source null
    related pmid
    26482275
    relationship
    Comment in
  2. citation
    Nat Rev Urol. 2015 Dec;12(12):654. doi: 10.1038/nrurol.2015.262.
    note
    Source null
    related pmid
    26526757
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2016 Jul;17(7):e270. doi: 10.1016/S1470-2045(16)30233-9.
    note
    Source null
    related pmid
    27733289
    relationship
    Erratum in
  4. citation
    Lancet Oncol. 2018 Oct;19(10):e509. doi: 10.1016/S1470-2045(18)30672-7.
    note
    Source null
    related pmid
    30303125
    relationship
    Erratum in

Authors and identifiers

  1. name
    Motzer RJ
    type
    Author
  2. name
    Hutson TE
    type
    Author
  3. name
    Glen H
    type
    Author
  4. name
    Michaelson MD
    type
    Author
  5. name
    Molina A
    type
    Author
  6. name
    Eisen T
    type
    Author
  7. name
    Jassem J
    type
    Author
  8. name
    Zolnierek J
    type
    Author
  9. name
    Maroto JP
    type
    Author
  10. name
    Mellado B
    type
    Author
  11. name
    Melichar B
    type
    Author
  12. name
    Tomasek J
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Motzer RJ
    type
    Author
  2. name
    Hutson TE
    type
    Author
  3. name
    Glen H
    type
    Author
  4. name
    Michaelson MD
    type
    Author
  5. name
    Molina A
    type
    Author
  6. name
    Eisen T
    type
    Author
  7. name
    Jassem J
    type
    Author
  8. name
    Zolnierek J
    type
    Author
  9. name
    Maroto JP
    type
    Author
  10. name
    Mellado B
    type
    Author
  11. name
    Melichar B
    type
    Author
  12. name
    Tomasek J
    type
    Author
bibliography ids
  1. nci-bib-b12420a82ddd184624e6ac96
book metadata
content sha256
8b26bb55abe71ef01991bd4f6e165866edb13a2c0f514ffc6a4085a308a6551c
document type
citation
dois
  1. 10.1016/S1470-2045(15)00290-9
electronic publication date
display
2015 Oct 22
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26482279
immutable id
pubmed:26482279@8b26bb55abe71ef01991bd4f6e165866edb13a2c0f514ffc6a4085a308a6551c
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
15
name
The Lancet. Oncology
nlm unique id
100957246
pages
1473-1482
volume
16
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2015 Nov;16(15):1441-1442. doi: 10.1016/S1470-2045(15)00325-3.
    note
    Source null
    related pmid
    26482275
    relationship
    Comment in
  2. citation
    Nat Rev Urol. 2015 Dec;12(12):654. doi: 10.1038/nrurol.2015.262.
    note
    Source null
    related pmid
    26526757
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2016 Jul;17(7):e270. doi: 10.1016/S1470-2045(16)30233-9.
    note
    Source null
    related pmid
    27733289
    relationship
    Erratum in
  4. citation
    Lancet Oncol. 2018 Oct;19(10):e509. doi: 10.1016/S1470-2045(18)30672-7.
    note
    Source null
    related pmid
    30303125
    relationship
    Erratum in
outcomes validated
false
pmid
26482279
provenance
batch id
4c1ece5bfc3d8e2be622
provider
NCBI PubMed ESummary
record sha256
5d931090d39e6536a6e4ff220e3f2ba26734b7df6c8bf894b7e51a6066a35429
response sha256
85f81bf7b60c457e4b5806b47c7c67c745ada2ae114069aa45de5ef977770dba
retrieved at
2026-09-09T23:47:12.730551+00:00
publication date
display
2015 Nov
precision
month
year
2015
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26482279/
title
Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial.

Preserved source evidence · Not medical advice